UnitedHealth Group Incorporated $UNH Shares Purchased by Kingdom Financial Group LLC.

Kingdom Financial Group LLC. grew its position in UnitedHealth Group Incorporated (NYSE:UNH) by 456.7% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 2,444 shares of the healthcare conglomerate’s stock after buying an additional 2,005 shares during the quarter. UnitedHealth Group makes up approximately 0.7% of Kingdom Financial Group LLC.’s portfolio, making the stock its 17th largest position. Kingdom Financial Group LLC.’s holdings in UnitedHealth Group were worth $762,000 at the end of the most recent reporting period.

A number of other institutional investors also recently modified their holdings of UNH. LFA Lugano Financial Advisors SA bought a new position in UnitedHealth Group during the second quarter valued at approximately $25,000. Bayforest Capital Ltd grew its stake in shares of UnitedHealth Group by 685.7% in the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate’s stock worth $29,000 after acquiring an additional 48 shares during the last quarter. Islay Capital Management LLC acquired a new stake in UnitedHealth Group during the second quarter worth about $31,000. Clal Insurance Enterprises Holdings Ltd raised its stake in shares of UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate’s stock valued at $32,000 after purchasing an additional 50 shares in the last quarter. Finally, Glass Jacobson Investment Advisors llc increased its stake in UnitedHealth Group by 80.9% in the second quarter. Glass Jacobson Investment Advisors llc now owns 123 shares of the healthcare conglomerate’s stock valued at $38,000 after acquiring an additional 55 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

UNH opened at $313.77 on Wednesday. The firm has a market capitalization of $284.22 billion, a PE ratio of 16.38, a PEG ratio of 2.28 and a beta of 0.47. The company has a debt-to-equity ratio of 0.71, a quick ratio of 0.85 and a current ratio of 0.82. The business’s 50-day simple moving average is $346.96 and its 200 day simple moving average is $317.63. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $622.83.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping the consensus estimate of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The company had revenue of $113.16 billion for the quarter, compared to analyst estimates of $113.19 billion. During the same period in the previous year, the business earned $7.15 EPS. UnitedHealth Group’s revenue for the quarter was up 12.2% compared to the same quarter last year. As a group, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 16th. Stockholders of record on Monday, December 8th will be paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 46.14%.

Analyst Ratings Changes

UNH has been the topic of a number of analyst reports. Leerink Partners set a $410.00 price target on UnitedHealth Group and gave the company an “outperform” rating in a research report on Wednesday, October 29th. Wells Fargo & Company boosted their price objective on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 7th. Bank of America boosted their price target on shares of UnitedHealth Group from $350.00 to $390.00 and gave the stock a “neutral” rating in a research note on Wednesday, October 8th. Baird R W cut UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. Finally, Morgan Stanley upped their price objective on shares of UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research report on Friday, September 12th. Eighteen analysts have rated the stock with a Buy rating, nine have issued a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average target price of $397.12.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.